ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,421Medicare Part D Prescriptions Filled, Including Refills

Rank: 53 out of 939

$847K Total Retail Price of All Prescriptions

Rank: 76 out of 939

559 Patients Receiving at Least One Drug in Part D
59%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 559 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 559 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 10,680 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
LEVOTHYROXINE SODIUM 766 523 1 4
SIMVASTATIN 682 440 2 2
METOPROLOL TARTRATE 586 371 3 10
HYDROCODONE-ACETAMINOPHEN 528 240 S3 4 1
GABAPENTIN 512 304 5 11
OMEPRAZOLE 462 276 6 5
TRAMADOL HCL 438 236 7 16
POTASSIUM CHLORIDE 406 283 8 9
FUROSEMIDE 362 239 9 7
METFORMIN HCL 356 173 10 8
ENALAPRIL MALEATE 330 193 11 65
ZOLPIDEM TARTRATE 320 158 12 20
LISINOPRIL 318 203 13 3
WARFARIN SODIUM 306 212 14 17
AMLODIPINE BESYLATE 245 189 15 6
HYDROCHLOROTHIAZIDE 242 144 16 12
TAMSULOSIN HCL 228 142 17 27
ATORVASTATIN CALCIUM 228 136 17 22
METOPROLOL SUCCINATE 225 199 19 21
CLONIDINE HCL 222 121 20 39
NEXIUM 220 90 21 18
LOVASTATIN 190 154 22 46
SERTRALINE HCL 184 91 23 24
FELODIPINE ER 170 127 24 255
RANITIDINE HCL 169 90 25 35
CITALOPRAM HBR 169 81 25 15
CYCLOBENZAPRINE HCL 166 81 R 27 36
CARVEDILOL 163 122 28 25
CLOPIDOGREL 161 103 29 28
FLUOXETINE HCL 157 66 30 47
TIZANIDINE HCL 154 49 31 81
LOSARTAN POTASSIUM 152 115 32 29
GLIPIZIDE 144 69 33 52
AMOXICILLIN 141 65 34 92
GLIPIZIDE ER 138 68 35 88
MELOXICAM 135 68 36 14
NAPROXEN 134 61 37 72
PROAIR HFA 120 58 38 41
ALENDRONATE SODIUM 120 97 38 40
AZITHROMYCIN 118 76 40 32
ATENOLOL 115 80 41 19
TOPIRAMATE 113 34 42 154
AGGRENOX 110 75 43 153
BUSPIRONE HCL 108 33 44 123
ESTRADIOL 103 55 R 45 79
PRAVASTATIN SODIUM 102 55 46 13
OXYBUTYNIN CHLORIDE 98 81 47 125
ZETIA 97 57 48 103
PREDNISONE 97 79 48 42
DONEPEZIL HCL 96 82 50 30
MIRTAZAPINE 94 63 51 56
ADVAIR DISKUS 94 49 51 60
ENALAPRIL-HYDROCHLOROTHIAZIDE 90 44 53 192
TRIAMTERENE-HCTZ 88 39 54 33
QUETIAPINE FUMARATE 86 41 55 69
PLAVIX 85 62 56 48
AMITRIPTYLINE HCL 83 42 R 57 38
TRAZODONE HCL 81 24 58 26
CYMBALTA 79 20 59 44
CRESTOR 78 28 60 34
DIGOXIN 77 60 61 45
COMBIVENT 76 26 62 120
GEMFIBROZIL 76 52 62 100
VENLAFAXINE HCL 75 43 64 159
CEFADROXIL 71 36 65 251
NAMENDA 71 60 65 49
PROMETHAZINE HCL 69 0 R 67 68
FLUTICASONE PROPIONATE 69 22 67 43
DIOVAN 67 59 69 50
SINGULAIR 66 27 70 101
INSULIN SYRINGE 66 21 70 97
VENLAFAXINE HCL ER 65 47 72 121
CIPROFLOXACIN HCL 65 43 72 54
AVODART 65 40 72 205
DOXYCYCLINE HYCLATE 61 38 75 84
DOXAZOSIN MESYLATE 60 47 76 108
ALLOPURINOL 59 40 77 31
DILTIAZEM ER 59 55 77 94
NYSTATIN 55 29 79 174
VENTOLIN HFA 55 30 79 80
OXYCODONE HCL 55 12 S2 79 67
HYDROXYZINE PAMOATE 54 0 R 82 220
LANTUS 53 27 83 59
SUCRALFATE 51 24 84 96
LOSARTAN-HYDROCHLOROTHIAZIDE 50 29 85 55
DILTIAZEM 24HR CD 50 41 85 126
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.